Menu

Summary

Global experts explore the gene regulation of hemoglobin; the pathophysiology of iron overload, clinical management, emerging therapies, co-morbidities, and updates from clinical trials using gene addition, gene editing, and alternative donor source hematopoietic stem cell transplantation, among other topics central to thalassemia syndromes.

Registration

This event has been completed.

Download Agenda